Next Article in Journal
Community-Acquired and Healthcare-Associated Sepsis: Characteristics and in-Hospital Mortality in Italy
Next Article in Special Issue
Brazilian Red Propolis Is as Effective as Amoxicillin in Controlling Red-Complex of Multispecies Subgingival Mature Biofilm In Vitro
Previous Article in Journal
Molecular Typing, Characterization of Antimicrobial Resistance, Virulence Profiling and Analysis of Whole-Genome Sequence of Clinical Klebsiella pneumoniae Isolates
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 9
Issue 5
10.3390/antibiotics9050262
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antagonistic Activity against Ascosphaera apis and Functional Properties of Lactobacillus kunkeei Strains

by
Massimo Iorizzo
1,
Silvia Jane Lombardi
1,
Sonia Ganassi
1,
Bruno Testa
1,*,
Mario Ianiro
1,
Francesco Letizia
1,
Mariantonietta Succi
1,
Patrizio Tremonte
1,
Franca Vergalito
1,
Autilia Cozzolino
1,
Elena Sorrentino
1,
Raffaele Coppola
1,
Sonia Petrarca
2,
Massimo Mancini
1 and
Antonio De Cristofaro
1
1
Department of Agriculture, Environmental and Food Sciences, University of Molise, 86100 Campobasso, Italy
2
CONAPROA, Consorzio Nazionale Produttori Apistici, 86100 Campobasso, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2020, 9(5), 262; https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9050262
Submission received: 30 March 2020 / Revised: 15 May 2020 / Accepted: 17 May 2020 / Published: 18 May 2020
(This article belongs to the Special Issue Honey Bee Products as an Alternative or Complement to Classical Antibiotics)
Browse Figures
Versions Notes

Abstract

:
Lactic acid bacteria (LAB) are an important group of honeybee gut microbiota. These bacteria are involved in food digestion, stimulate the immune system, and may antagonize undesirable microorganisms in the gastrointestinal tract. Lactobacillus kunkeei is a fructophilic lactic acid bacterium (FLAB) most frequently found in the gastrointestinal tracts of honeybees. Ascosphaera apis is an important pathogenic fungus of honeybee larvae; it can colonize the intestine, especially in conditions of nutritional or environmental stress that cause microbial dysbiosis. In this work, some functional properties of nine selected L. kunkeei strains were evaluated. The study focused on the antifungal activity of these strains against A. apis DSM 3116, using different matrices: cell lysate, broth culture, cell-free supernatant, and cell pellet. The cell lysate showed the highest antifungal activity. Moreover, the strains were shown to possess good cell-surface properties (hydrophobicity, auto-aggregation, and biofilm production) and a good resistance to high sugar concentrations. These L. kunkeei strains were demonstrated to be functional for use in “probiotic syrup”, useful to restore the symbiotic communities of the intestine in case of dysbiosis and to exert a prophylactic action against A. apis.

1. Introduction

1.1. Ascosphaera apis: The Causative Agent of Chalkbrood Disease

The eusocial nature of Apis mellifera has always facilitated the maintenance of a relatively constant gut microbiota. This is due to interactions among individuals in the hive environment, and mainly to trophallaxis. This term refers to the direct transfer of food or fluids from one individual to another; it is especially common among social insects such as honeybees. Along with nutrients, trophallaxis also allows the horizontal transmission of gut bacteria [1,2]. The stomachs of honeybees are full of nutrients and are therefore a favorable environment for symbiotic microorganisms. These take part in various processes, including food digestion, detoxification of harmful molecules, supply of essential nutrients, participation in the host defense system, and protection from pathogens and parasites. The gut microbiota can be influenced by various factors that can cause dysbiosis, including temperature, nutritional deficiencies, pesticides, parasites, or pathogens [3,4,5,6,7]. Gut microflora alteration may have a strong negative impact on bee immune defense, metabolism, and cognitive mechanisms [4]. The honeybee intestine, which functions in digestion and food processing, is also the site of infections caused by pathogens such as A. apis, Nosema ceranae, Paenibacillus larvae, and probably by many of the honeybee viruses [4,5,6,7]. Chalkbrood is a fungal disease of the honeybee caused by the opportunistic pathogen A. apis, belonging to the heterothallic Ascomycota. This disease is now found throughout the world, and there are indications that the incidence of chalkbrood may be on the rise [8]. The severity of the disease depends on various factors such as environmental conditions, the genetic background and general health status of the honeybees, and the virulence level of the fungal strains [8,9,10,11,12,13]. Honeybee larvae are initially infected by ingesting food contaminated by sexual spores of A. apis. The ascospores germinate in the anaerobic environment of the alimentary canal, and the hyphae of the mycelium subsequently penetrate the intestinal walls of the larvae and deprive them of nutrients [8,9]. After a few days, the fungus becomes visible as a fluffy white growth covering the larvae. Chalkbrood can cause a reduction in honey production and a high percentage of larvae deaths, with significant economic consequences for beekeepers [8,11,13]. The initial phase of infection can be facilitated by any nutritional or environmental stress that causes microbial dysbiosis [4,5,6].

1.2. Chalkbrood Disease Control by Symbiotic Bacteria

The use of intestinal microbial symbionts, such as via dietary supplementation, can improve the health status of bees and increase their productivity, stimulating the immune defenses and exerting an antimicrobial action against unwanted and pathogenic microflora [14,15,16,17,18,19,20]. The presence of lactic acid bacteria (LAB) in the honeybee digestive system has been consistently reported in literature [21], and L. kunkeei is a bacterium frequently present in the intestinal microbiota of honeybees. It colonizes fructose-rich niches and is actually classified as fructophilic lactic acid bacterium (FLAB) [22,23,24]. L. kunkeei seems to protect its niche against bacterial competitors, although the mechanism of its antimicrobial activity is still in many respects unknown [25]. Some authors have assumed that the antimicrobial mechanisms of symbiotic bacteria evolved synergistically with bees, with the purpose of defending themselves and their hosts [2,6]. Inhibition could be based on a combination of active compounds such as proteins, peptides, fatty acids, organic acids, and hydrogen peroxide [26]. Furthermore, the ability of L. kunkeei to colonize the intestine and form a biofilm creates a barrier against unwanted microorganisms [26,27]. While there are many scientific data on the antimicrobial activity of L. kunkeei towards other microorganisms, and on that of other bacterial species against A. apis [28,29,30,31,32,33,34], reports of antifungal activity of L. kunkeei against A. apis are still few [35]. In recent years, a number of different strategies have been developed and implemented to control chalkbrood disease. A broad range of chemotherapeutic compounds have been tested for their ability to control A. apis [36,37]. Unfortunately, none of the compounds tested have been able to prevent the disease [38]. Furthermore, pesticide and antifungal chemical residues in honey represent a major human health hazard [39]. There is increased interest in investigations into new and effective chalkbrood control methods. The use of natural compounds for the disease control also represents an alternative. Some essential oils and other botanical extracts from plants, herbs, and spices exhibit antimicrobial activity against A. apis [40,41,42,43,44,45]. This antimicrobial activity is mainly due to the presence of phenolic and terpenoid compounds, which have well-known antimicrobial activity. However, the effect that these substances may have on bees’ intestinal microflora and symbiotic LAB is not wholly known [46,47,48,49,50,51,52]. According to these considerations, the use of symbiotic FLAB in the prevention and biocontrol of honeybee pathogenic microorganisms, including chalkbrood disease, offers interesting possibilities [18]. The use of symbiotic bacteria, unlike synthetic or natural chemical compounds, does not adversely affect the balance of gut microbiota or impact honeybee health [4,7,21,33].
In this research, the antifungal activity of nine L. kunkeei strains against A. apis was evaluated. Moreover, further functional characteristics (auto-aggregation, biofilm production, hydrophobicity, and osmotic tolerance) were also assayed to assess suitability for use in a “probiotic syrup” to enhance the honeybee diet.

2. Results

2.1. Screening of Bacteria for Antifungal Activity

In the preliminary antifungal tests, all 85 L. kunkeei strains showed antifungal activity, but with different intensity: 8 strains had low intensity, 54 strains had medium intensity, and 23 strains had high intensity (Supplementary Materials Table S1).
Among the 23 strains that showed high antifungal activity, the strains K7, K18, K34, K40, K41, K45, K55, K64, and K112 caused 100% inhibition and were selected for further biological control tests against A. apis DSM 3116 and subsequent analyses.

2.2. Determination of Inhibitory Activity

Figure 1 presents a heatmap of the inhibitory activity against A. apis DSM 3116 of the various matrices obtained from bacterial cell cultures. The broth cultures (BCs) of the nine selected strains confirmed total inhibition against the fungus, as already highlighted in the previous screening test.
In tests where the other matrices Cell Lysate (CL), Cell Pellet (CP) and Cell-Free Supernatant (CFS) were used, there was variability with often significant differences. Numeric data are shown in Supplementary Materials Table S2.
The CLs inhibited the fungus more than other matrices; in particular, the K7, K41, K45, and K55 L. kunkeei strains caused inhibition of more than 90%. The CPs showed a high inhibitory activity ranging from 60% to 80%, with the exception of the L. kunkeei K40 strain (19.8%). The CFSs showed overall less inhibitory activity, between 8% and 24%, with the exception of the CFS of L. kunkeei K7, which caused 53.8% inhibition (Figure 2).

2.3. Hydrophobicity and Auto-Aggregation

This section reports the results of the tests of hydrocarbon adhesion and the auto-aggregation capacity of the selected L. kunkeei strains. The results are displayed graphically in Figure 3 and numerically in Supplementary Materials Table S3.
The hydrophobicity was highly variable depending on the strain and the hydrocarbon used, with significant differences in almost all cases. All the strains showed high adherence to toluene, while only three strains (K34, K41, and K55) showed high adherence to xylene. The adhesion to the two hydrocarbons gradually increased during the 60 min of tests, and the percentage of hydrophobicity obtained with toluene was significantly higher than that with xylene. In the test with toluene, three strains (K7, K34, and K41) showed an affinity greater than 90% after 60 min; the other strains showed a high hydrophobicity between 80% and 90%.
In the test with xylene, three strains (K34, K41, and K55) showed high hydrophobicity greater than 70%; the K7, K18, K40, K45, K64, and DSM 12361 strains showed moderate hydrophobicity between 45% and 66%; K112 alone showed a low affinity (31.91%).
The results of the auto-aggregation test are shown in Table 1. All nine strains demonstrated an ability of auto-aggregation that progressively and significantly increased over time.
The data showed significant differences among the various strains after 1, 2 and 5 h. After 24 h, there was less variability; in fact, the auto-aggregation capacity of the K7, K40, K64, K112, and DSM 12361 strains, ranging between 53.42% and 56.52%, was not significantly different.

2.4. Biofilm Production

Figure 4 shows the heatmap of biofilm production in MRS broth without sugar or supplemented with 1% glucose, 1% fructose, or 1% sucrose. The amount of biofilm was assessed by measuring the optical density (OD), and numerical data are provided in Supplementary Materials Table S4. All the L. kunkeei strains tested were able to produce biofilms, but in different amounts depending on the presence and type of added sugar.
With the addition of 1% of glucose or 1% fructose, the biofilm production for each bacterial strain was similar, but among the various strains, the OD values were significantly different.
In MRS without sugar, five strains (K34, K41, K55, K64, and DSM 12361) produced the largest amounts of biofilm, to a significantly different degree than the other strains. With the addition of sucrose, the largest amounts of biofilms were produced by K7, K18, K34, K40, K41, K45, and K55 L. kunkeei strains, with the differences among them not statistically significant.

2.5. Bacterial Survival in Sugar Syrup

The results of strains’ survival in sugar syrup are shown in Table 2. In Test A (40% glucose + 20% fructose, pH 4.2), after 24 h of incubation, all the strains maintained a high viable cell density between 6.90 and 8.10 log CFU/mL; after 48 h, although with significant differences, the all strains maintained a good cell density ranging between 4.80 and 7.51 log CFU/mL.
In Test B (40% glucose + 30% fructose at pH 4.2), after 24 h, the bacteria, except the strains DSM 12361 and K112, showed concentrations of viable cells greater than 6.0 log CFU/mL; after 48 h, only K18 and K55 maintained a good viable cell density (>5.0 log CFU/mL), with results significantly different from the other strains. The lowest concentration was that of the DSM 12361 strain (2.91 log CFU/mL). In Test C (50% of sucrose at pH 4.2), after 24 h, the concentration of viable cells for all strains was between 7.10 and 8.50 log CFU/mL, while after 48 h, although with significant differences, all strains maintained a good viable cell density between 5.94 and 7.94 log CFU/mL.

3. Discussion

3.1. Antifungal Activity

In the inhibition test against A. apis, all nine L. kunkeei strains showed strong antifungal activity. Complete inhibition occurred with the use of BC, which was most likely due to the interaction of several factors. The inhibitory effects observed when using CP and CL were stronger than those obtained with the CFS. Our results suggest that the antimicrobial action of LAB is often due to a complex interaction among different compounds (e.g., organic acids, fatty acids, proteinaceous compounds, phenolic acids, hydrogen peroxide, reuterin) contained in the different matrices used, as highlighted in other research [53,54,55,56]. The action in CP could be based on either nutritional competition or compounds linked to their walls. The major inhibitory effect after cell lysis is probably due to the release of further antimicrobial compounds from the cell wall or from the cytoplasm. In general, LAB can produce extracellular proteins such as bacteriocins, molecular chaperones, enzymes, and lipoproteins [57]. Glycolytic and ribosomal proteins generally contained in the cytoplasm can be found on the bacterial cell surface. It is hypothesized that these proteins, once they are localized on the surface, could develop different functions such as biofilm production and antimicrobial activity [21,58,59]. The L. kunkeei strains tested in our experiments were shown to possess substances biologically active against A. apis. Our results confirmed a potentially antagonist role of L. kunkeei against pathogenic microorganisms that use the digestive channels of bees as a site of infection [22,60,61].

3.2. Cell-Surface Properties

The ability of probiotic bacteria to adhere to intestinal epithelial cells involves various surface properties, including hydrophobicity and auto-aggregation. These characteristics are an important prerequisite for colonization of the host intestinal tract [62,63,64,65,66,67]. The probiotic bacteria are linked to the receptors of intestinal mucosa, thus preventing the adherence of pathogenic microorganisms which are subsequently eliminated from the intestine [62,63]. The quality of adherence, usually strain-specific, can also cause increased persistence in the gastrointestinal tract. The adherence property is most likely due to complex interactions between positive and negative charges between hydrophobic and hydrophilic components of the bacterial surface [64]. As reported in previous studies, hydrophobicity, together with auto-aggregation, is considered an important bacterial surface feature [65,66], and correlations between them may be observed [67]. In our study, the hydrophobicity was evaluated by BATH method using two different hydrocarbons, xylene and toluene [67], and classified into three groups: low (0% to 35%), moderate (36% to 70%), and high hydrophobicity (71% to 100%) [68]. The BATH assay showed significant variations depending on the hydrocarbon used. The nine L. kunkeei strains all showed an enhanced adherence capacity to toluene than xylene. In previous studies, it has been reported that the viscosity of the hydrocarbon or the size of droplets formed during mixing may determine this difference [69].
In the future, it will be necessary to perform this assay with cell lines to confirm the adhesion of the tested strains to epithelial cells.
Auto-aggregation is a characteristic that promotes the stability of microbial strains in the gastrointestinal tract (GIT). This phenotypic characteristic, as several studies have shown, can be constitutive or induced by nutritional and environmental stress conditions (pH, temperature, presence of competing microorganisms, etc.) [63,64,65,66,67,68,69,70]. Our results showed that the nine L. kunkeei strains had high values of auto-aggregation, in line with previous research [71]. The bacterial auto-aggregation capacity is related to the building of a biofilm. Some microorganisms have the ability to form biofilms to adhere to surfaces. Bacterial biofilm production is a highly complex process depending on the expression of specific genes, and this process is a means by which to adapt to new nutritional and environmental conditions [70]. Several studies have reported that in this phase of adaptation, bacteria produce extracellular polymeric substances (EPS), especially exopolysaccharides and proteinaceous compounds, that may be constituents of the biofilm and could exert an antimicrobial action [72,73,74,75,76].
In our study, all the L. kunkeei strains were shown to be able to produce biofilm, with different intensities.
In this regard, the best results were obtained with the use of 1% sucrose and without adding sugar. According to some authors, it would seem that in the presence of a nutritional stress, the strains used the biofilm as a defense mechanism [21,77,78,79]. Thanks to its ability to produce biofilms, L. kunkeei persists in the intestine where there is an extensive flow of sugars, enzymes, and water, and the constant invasion of foreign microbes following the ingestion of flower nectar during foraging. As highlighted in other research, the biofilms formed by some L. kunkeei strains favor their persistence in the bee intestine and increase their inhibition power against undesirable microorganisms [15,18,20,79].

3.3. Survival in Sugar Syrups

In our experimental studies, we evaluated the capacity of L. kunkeei strains to tolerate a high concentration of sugars to verify their functionality as probiotics in a sugar syrup used as additional nutrition for bees. The results proved that all nine strains, in all combinations, had a good osmotic tolerance, in agreement with a previous study [22]. This feature would ensure a high bacterial vitality if L. kunkeei were added to sugar syrups used as additional food in hives. Moreover, honeybees are attracted by highly concentrated sugar syrup; this behavior becomes important when finding a compromise between maximum attractiveness for bees and survival of lactic bacteria.

3.4. Perspectives

Several studies have shown that the use of probiotic bacteria in honeybee diet may have several positive effects, including increasing the immune defenses of bees, strengthening or rebalancing the intestinal microflora in case of dysbiosis, improving bee productivity, and strengthening defense systems against pathogenic microorganisms [3,23,30,31,32,33,34,35,80,81,82,83,84,85].
The novelty of our work was to select nine symbiotic L. kunkeei strains for use in a honeybee diet for prophylactic and therapeutic purposes against A. apis. The selected L. kunkeei strains showed functional properties (cell surface properties, antifungal activity, and osmotic tolerance) for use as probiotics in sugar syrups to be used in the supplemental feeding of honeybees.

4. Materials and Methods

4.1. Microbial Cultures

For this study, 85 selected L. kunkeei strains were used, isolated from bee bread, honey stomach, and honeybee guts of Apis mellifera L. (Supplementary Materials Table S1). These bacteria belong to the Di.A.A.A (Department of Agricultural, Environmental and Food Sciences) collection of University of Molise [85].
A. apis DSM 3116 and L. kunkeei DSM 12361, belonging to the DSMZ collection (German Collection of Microorganism and Cell Cultures GmbH), were used as reference cultures. We used the DSM 12361 strain as a reference because it has demonstrated a capacity in previous research to produce EPS [76,77,78].

4.2. Screening of Bacteria for Antifungal Activity

The antifungal activity screening for the 85 L. kunkeei strains was performed using the overlay method as described by Magnusson et al. [86], with some modification. The strains were cultivated in MRS broth (Oxoid Ltd., Hampshire, UK) at 37 °C for 12 h, after which 10 μL of the bacterial culture (108 CFU/mL) was spotted onto the surface of MRS agar plates and plates were incubated at 37 °C for 24 h. Fungal culture of A. apis DSM 3116 was obtained by growing on a MEA plate (Oxoid Ltd., Hampshire, UK) aerobically at 37 °C for 5 days. After that, a mycelium disc of 6 mm diameter was taken, dissolved in physiological solution (0.9% NaCl), and vortexed for 5 min; subsequently, 1 mL of the fungal suspension was inoculated into a tube containing 9 mL of MEA soft agar (0.05% malt extract and 0.7% agar) that was overlaid in the Petri dishes with the various bacterial strains. A plate containing MEA with fungal suspension and without bacteria was used as a control. After 72 h of incubation at 37 °C, the inhibition activity was measured as the diameter (mm) of the clear zone around the bacterial spot; the different activity levels of the bacteria were classified as follows: 0–30 mm: low activity; 30–60 mm: medium activity; >60 mm: high activity.

4.3. Determination of Inhibitory Activity

The inhibitory activity was performed using the following matrices: BC, CP, CFS, and CL. In order to obtain the fractions, every single strain was cultivated in MRS broth and incubated at 37 °C for 12 h, reaching a cell concentration of 108 CFU/mL. This culture without any further treatment was the BC matrix. Five milliliters of the bacterial culture were centrifuged at 8000 rpm for 15 min at 4 °C. After centrifugation, the supernatant was sterilized by filtration (0.22 μm pore size cellulose acetate filter), and this fraction represented the CFS. The remaining pellet was washed and resuspended in 5 mL of physiological solution, which was the CP fraction. In order to obtain the CL fraction, 5 mL of the BC was centrifuged and the pellet washed, resuspended in 5 mL of physiological solution, and sonicated (20 kHz for 30 min a 45 °C) to promote cellular lysis. A volume of 5mL of each matrix (BC, CP, CFS, and CL), was added to 15 mL of MEA; the preparation was poured into 90 mm Petri dishes. After solidification, a mycelium disc (6 mm diameter) of A. apis (DSM 3116) was placed in the middle of each Petri dish and incubated at 37 °C in aerobic conditions. The antifungal activity was evaluated by measuring the hyphal radial growth (cm diameter) after 6 days of incubation and expressed as percentage of inhibition using the following formula: % I = [1 − (Ds/Dc)] × 100, where Ds was the hyphal diameter of the sample and Dc was the hyphal diameter of the control (MEA only with fungus).

4.4. Hydrophobicity Assay

The determination of cell-surface hydrophobicity was evaluated on L. kunkeei strains basing on the bacterial ability to adhere to hydrocarbons (BATH), according to the procedure described by Cozzolino et al. [87], using xylene and toluene as solvents. The bacteria were grown overnight at 37 °C in MRS broth. Cultures were collected by centrifugation (8000 rpm for 10 min at 4 °C) during the logarithmic growth phase, washed twice and resuspended in physiological solution to an optical density of approx. 0.5 (A580), in order to standardize the bacterial concentration at 108 CFU/mL. An equal volume of hydrocarbon (xylene or toluene) was then added to the bacterial suspension, mixed (in a vortex-type mixer) for 5 min and incubated at 37 °C. The aqueous phase was carefully removed after 15, 30, and 60 min of incubation at room temperature and the absorbance was measured at 580 nm using a spectrophotometer (PerkinElmer 1420 Multilabel Counter). Hydrophobicity was calculated as the percentage decrease in OD of the initial bacterial suspension and was expressed using the following formula: % Hydrophobicity = (OD0 − ODt/OD0) × 100, where ODt represents the absorbance value after extraction with hydrocarbons (15, 30, and 60 min) and OD0 represents the absorbance value before extraction with hydrocarbons. The L. kunkeei strains were classified into three roups on the basis of their affinity to hydrocarbons: low (0% to 35%), moderate (36% to 70%), and high hydrophobicity (71% to 100%) [68].

4.5. Auto-Aggregation

The auto-aggregation assay was performed according to Collado et al. [67]. The bacterial suspensions were prepared as described for BATH test. Auto-aggregation was measured at 1, 2, 5, and 24 h of incubation at 37 °C, after which the OD at 580nm of the upper suspension was measured using a spectrophotometer (PerkinElmer 1420 Multilabel Counter). The percentage of auto-aggregation was calculated using the following formula: Auto-aggregation % (A) = (1 − ODt/OD0) × 100 where OD0 is the absorbance at time 0 and ODt is the absorbance detected after 1, 2, 5, and 24 h [64].

4.6. Biofilm Production

Biofilm production was evaluated as described by Cozzolino et al. [87] with some modifications. L. kunkeei strains were grown overnight at 37 °C in MRS broth. The bacterial cells were harvested by centrifugation at 8000 rpm for 10 min at 4 °C, washed twice with PBS (Sigma-Aldrich), and resuspended in MRS broth without glucose (Liofilchem, Italy) and in MRS broth supplemented with 1% glucose, 1% fructose, or 1% sucrose. Three aliquots of 200 μL of each bacterial suspension were added to a 96 well polystyrene microtiter plate. Negative controls were constituted by wells filled with uninoculated culture media. Microtiter plates were incubated for 24 h at 37 °C. The medium was removed from each well and plates were washed three times with a sterile physiological solution to remove unattached cells. The remaining attached cells were fixed with 200 μL of 99% methanol (Sigma–Aldrich) per well. After 15 min, wells were emptied and left to dry. Wells were then stained for 5 min with 200 μL of 2% crystal violet (Liofilchem, Italy) per well. The excess stain was removed by washing three times with a sterile saline solution. After the plates were air-dried, the adherent cells were resuspended in 160 μL of 33% (v/v) glacial acetic acid (Sigma–Aldrich). The absorbance values at 580 nm, measured using an automated Multilabel Counter (PerkinElmer 1420), represent the biofilm formation capacity.

4.7. Bacterial Survival in Sugar Syrup

The L. kunkeei strains were grown overnight in MRS broth at 37 °C. After that, cells were harvested by centrifugation at 8000 rpm for 10 min at 4 °C. The fresh pellets were washed twice with physiological solution and inoculated into the sugar syrup in order to measure an initial concentration of 108 CFU/mL. The experimental conditions were as follows: Test A: sugar syrup constituted of 40% glucose + 20% fructose in distilled water at pH 4.2; Test B: sugar syrup constituted of 40% glucose + 30% fructose in distilled water at pH 4.2; Test C: sugar syrup constituted of 50% sucrose in distilled water at pH 4.2. The sugar syrup was acidified using HCl 1N and sterilized by filtration (0.22 μm pore size cellulose acetate filter). The experiments were performed at 20 °C. The cell viability of the bacteria was determined at 0, 24, and 48 h by plating on MRS agar (37 °C for 72 h in anaerobic conditions).

4.8. Statistical Analysis

All data are expressed as mean ± standard deviation (S.D.) of three independent experiments. Statistical analysis was performed via an analysis of variance (ANOVA) followed by the Tukey’s multiple comparison. Statistical significance was attributed to p-values < 0.05. The software SPSS (IBM SPSS Statistics 21) was used for the analysis.

5. Conclusions

The results showed the capacity of selected L. kunkeei strains to inhibit A. apis and highlighted their important properties, such as ability to form biofilms, high auto-aggregation, and hydrophobicity, all prerequisites for candidacy as probiotic microorganisms in a honeybee diet. In addition, the selected L. kunkeei strains showed high osmotic tolerance, a functional requirement for the probiotication of sugar syrups to restore or strengthen the symbiotic communities in honeybee guts in case of microbial dysbiosis.
Future research will be conducted in vivo/in situ on the antimicrobic activity of these bacteria and the effects on honeybee health and productivity.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/2079-6382/9/5/262/s1. Table S1: L. kunkeei strains collection; Table S2: Inhibition; Table S3: Hydrophobicity; Table S4: Biofilm production.

Author Contributions

Conceptualization, M.I. (Massimo Iorizzo) and R.C.; Data curation, M.S., P.T. and E.S.; Formal analysis, B.T., S.J.L., S.G., S.P., F.V. and A.C.; Funding acquisition, M.M. and A.D.C.; Investigation, B.T., S.P. and P.T.; Methodology, S.J.L., S.G., B.T., F.V. and A.C.; Project administration, S.P. and M.M.; Resources, R.C. and A.D.C.; Software, F.L. and M.M.; Supervision, R.C. and A.D.C.; Validation, M.S.; Writing—original draft, M.I. (Massimo Iorizzo) and B.T.; Writing—review & editing, M.I. (Mario Ianiro), S.G. and F.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was carried out as part of the project “BEEOBSERVER” financed by Department of Agriculture, Environmental and Food Sciences, University of Molise, CB, Italy. ID: H32F16000610005.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. Kwong, W.; Moran, N.A. Gut microbial communities of social bees. Nat. Rev. Microbiol. 2016, 14, 374–384. [Google Scholar] [CrossRef] [PubMed]
  2. Powell, J.E.; Martinson, V.G.; Urban-Mead, K.; Moran, N.A. Routes of acquisition of the gut microbiota of Apis mellifera. Appl. Environ. Microbiol. 2014, 80, 7378–7387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Cox-Foster, D.L.; Conlan, S.; Holmes, E.C.; Palacios, G.; Evans, J.D.; Moran, N.A.; Quan, P.L.; Briese, T.; Hornig, M.; Geiser, D.M.; et al. A metagenomic survey of microbes in honey bee colony collapse disorder. Science 2007, 318, 283–287. [Google Scholar] [CrossRef] [Green Version]
  4. Hamdi, C.; Balloi, A.; Essanaa, J.; Gonella, E.; Raddadi, N.; Ricci, I.; Boudabous, A.; Borin, S.; Manino, A.; Bandi, C.; et al. Gut microbiome dysbiosis and honeybee health. J. Appl. Entomol. 2011, 135, 524–533. [Google Scholar] [CrossRef] [Green Version]
  5. Maes, P.W.; Rodrigues, P.A.; Oliver, R.; Mott, B.M.; Anderson, K.E. Diet-related gut bacterial dysbiosis correlates with impaired development, increased mortality and Nosema disease in the honeybee (Apis mellifera). Mol. Ecol. 2016, 25, 5439–5450. [Google Scholar] [CrossRef] [PubMed]
  6. Schwarz, R.S.; Moran, N.A.; Evans, J.D. Early gut colonizers shape parasite susceptibility and microbiota composition in honey bee workers. Proc. Natl. Acad. Sci. USA 2016, 113, 9345–9350. [Google Scholar] [CrossRef] [Green Version]
  7. Raymann, K.; Shaffer, Z.; Moran, N.A. Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees. PLoS Biol. 2017, 15, e2001861. [Google Scholar] [CrossRef]
  8. Aronstein, K.A.; Murray, K.D. Chalkbrood disease in honey bees. J. Invertebr. Pathol. 2010, 103, 20–29. [Google Scholar] [CrossRef]
  9. Evison, S.E. Chalkbrood: Epidemiological perspectives from the host–parasite relationship. Curr. Opin. Insect Sci. 2015, 10, 65–70. [Google Scholar] [CrossRef]
  10. Garrido-Bailón, E.; Higes, M.; Martínez-Salvador, A.; Antúnez, K.; Botías, C.; Meana, A.; Prieto, L.; Martín-Hernández, R. The prevalence of the honeybee brood pathogens Ascosphaera apis, Paenibacillus larvae and Melissococcus plutonius in Spanish apiaries determined with a new multiplex PCR assay. Microb. Biotechnol. 2013, 6, 31–39. [Google Scholar] [CrossRef]
  11. Zaghloul, O.A.; Mourad, A.K.; El Kady, M.B.; Nemat, F.M.; Morsy, M.E. Assessment of losses in honey yield due to the chalck-brood disease with reference to the determination of its economic injury levels in Egypt. Commun. Agric. Appl. Biol. Sci. 2005, 70, 703–714. [Google Scholar] [PubMed]
  12. Reynaldi, F.J.; Lucia, M.; Garcia, M.L.G. Ascosphaera apis, the entomopathogenic fungus affecting larvae of native bees (Xylocopa augusti): First report in South America. Rev. Iberoam. Micol. 2015, 32, 261–264. [Google Scholar] [CrossRef] [PubMed]
  13. Vojvodic, S.; Boomsma, J.J.; Eilenberg, J.; Jensen, A.B. Virulence of mixed fungal infections in honey bee brood. Front. Zool. 2012, 9, 5. [Google Scholar] [CrossRef] [Green Version]
  14. Fowler, A.E.; Irwin, R.E.; Adler, L.S. Parasite defense mechanisms in bees: Behavior, immunity, antimicrobials, and symbionts. Emerg. Top. Life Sci. 2019, ETLS20190069. [Google Scholar] [CrossRef]
  15. Alberoni, D.; Baffoni, L.; Gaggiìa, F.; Ryan, P.M.; Murphy, K.; Ross, P.R.; Santon, C.; Di Gioia, D. Impact of beneficial bacteria supplementation on the gut microbiota, colony development and productivity of Apis mellifera L. Benef. Microbes 2018, 9, 269–278. [Google Scholar] [CrossRef] [PubMed]
  16. Ptaszyńska, A.A.; Borsuk, G.; Zdybicka-Barabas, A.; Cytryńska, M.; Małek, W. Are commercial probiotics and prebiotics effective in the treatment and prevention of honeybee nosemosis C? Parasitol. Res. 2016, 115, 397–406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Pătruică, S.; Mot, D. The effect of using prebiotic and probiotic products on intestinal micro-flora of the honeybee (Apis mellifera carpatica). Bull. Entomol. Res. 2012, 102, 619–623. [Google Scholar] [CrossRef]
  18. Audisio, M.C. Gram-positive bacteria with probiotic potential for the Apis mellifera L. honey bee: The experience in the Northwest of Argentina. Probiot. Antimicrob. Proteins 2017, 9, 22–31. [Google Scholar] [CrossRef]
  19. Audisio, M.C.; Benítez-Ahrendts, M.R. Lactobacillus johnsonii CRL1647, isolated from Apis mellifera L. bee-gut, exhibited a beneficial effect on honeybee colonies. Benef. Microbes 2011, 2, 29–34. [Google Scholar] [CrossRef]
  20. Baffoni, L.; Gaggiìa, F.; Alberoni, D.; Cabbri, R.; Nanetti, A.; Biavati, B.; Di Gioia, D. Effect of dietary supplementation of Bifidobacterium and Lactobacillus strains in Apis mellifera L. against Nosema ceranae. Benef. Microbes 2016, 7, 45–51. [Google Scholar] [CrossRef]
  21. Vásquez, A.; Forsgren, E.; Fries, I.; Paxton, R.J.; Flaberg, E.; Szekely, L.; Olofsson, T.C. Symbionts as major modulators of insect health: Lactic acid bacteria and honeybees. PLoS ONE 2012, 7, e33188. [Google Scholar] [CrossRef] [Green Version]
  22. Endo, A.; Irisawa, T.; Futagawa-Endo, Y.; Takano, K.; du Toit, M.; Okada, S.; Dicks, L.M. Characterization and emended description of Lactobacillus kunkeei as a fructophilic lactic acid bacterium. Int. J. Syst. Evol. Microbiol. 2012, 62, 500–504. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Endo, A.; Salminen, S. Honeybees and beehives are rich sources for fructophilic lactic acid bacteria. Syst. Appl. Microbiol. 2013, 36, 444–448. [Google Scholar] [CrossRef] [PubMed]
  24. Filannino, P.; Di Cagno, R.; Tlais, A.Z.A.; Cantatore, V.; Gobbetti, M. Fructose-rich niches traced the evolution of lactic acid bacteria toward fructophilic species. Crit. Rev. Microbiol. 2019, 45, 65–81. [Google Scholar] [CrossRef] [PubMed]
  25. Olofsson, T.C.; Butler, È.; Markowicz, P.; Lindholm, C.; Larsson, L.; Vásquez, A. Lactic acid bacterial symbionts in honeybees–an unknown key to honey’s antimicrobial and therapeutic activities. Int. Wound J. 2016, 13, 668–679. [Google Scholar] [CrossRef]
  26. Berríos, P.; Fuentes, J.A.; Salas, D.; Carreno, A.; Aldea, P.; Fernandez, F.; Trombert, A.N. Inhibitory effect of biofilm-forming Lactobacillus kunkeei strains against virulent Pseudomonas aeruginosa in vitro and in honeycomb moth (Galleria mellonella) infection model. Benef. Microbes 2018, 9, 257–268. [Google Scholar] [CrossRef]
  27. Butler, E.; Alsterfjord, M.; Olofsson, T.; Karlsson, C.; Malmström, J.; Vásquez, A. Proteins of novel lactic acid bacteria from Apis mellifera mellifera: An insight into the production of known extra-cellular proteins during microbial stress. BMC Microbiol. 2013, 13, 235. [Google Scholar] [CrossRef] [Green Version]
  28. Arredondo, D.; Castelli, L.; Porrini, M.P.; Garrido, P.M.; Eguaras, M.J.; Zunino, P.; Antúnez, K. Lactobacillus kunkeei strains decreased the infection by honey bee pathogens Paenibacillus larvae and Nosema ceranae. Benef. Microbes 2018, 9, 279–290. [Google Scholar] [CrossRef]
  29. Bartel, L.C.; Abrahamovich, E.; Mori, C.; Lopez, A.C.; Alippi, A.M. Bacillus and Brevibacillus strains as potential antagonists of Paenibacillus larvae and Ascosphaera apis. J. Apic. Res. 2019, 58, 117–132. [Google Scholar] [CrossRef]
  30. Al-Ghamdi, A.; Khan, K.; Ansari, M.; Almasaudi, S.; AL-Kahtani, S. Effect of gut bacterial isolates from Apis mellifera jemenitica on Paenibacillus larvae infected bee larvae. Saudi J. Biol. Sci. 2017, 25, 383–387. [Google Scholar] [CrossRef]
  31. Forsgren, E.; Olofsson, T.C.; Váasquez, A.; Fries, I. Novel lactic acid bacteria inhibiting Paenibacillus larvae in honey bee larvae. Apidologie 2010, 41, 99–108. [Google Scholar] [CrossRef] [Green Version]
  32. Janashia, I.; Choiset, Y.; Rabesona, H.; Hwanhlem, N.; Bakuradze, N.; Chanishvili, N.; Haertlé, T. Protection of honeybee Apis mellifera by its endogenous and exogenous lactic flora against bacterial infections. Ann. Agrar. Sci. 2016, 14, 177–181. [Google Scholar] [CrossRef]
  33. Omar, M.O.M.; Moustafa, A.M.; Ansari, M.J.; Anwar, A.M.; Fahmy, B.F.; Al-Ghamdi, A.; Nuru, A. Antagonistic effect of gut bacteria in the hybrid Carniolan honey bee, Apis Mellifera Carnica, against Ascosphaera apis, the causal organism of chalkbrood disease. J. Apic. Sci. 2014, 58, 17–27. [Google Scholar] [CrossRef] [Green Version]
  34. Sabaté, D.C.; Carrillo, L.; Audisio, M.C. Inhibition of Paenibacillus larvae and Ascosphaera apis by Bacillus subtilis isolated from honeybee gut and honey samples. Res. Microbiol. 2009, 160, 193–199. [Google Scholar] [CrossRef]
  35. Tejerina, M.R.; Cabana, M.J.; Carrillo, L.; Benitez-Ahrendts, M.R. Effect of Lactic Bacteria on Ascosphaera apis and A. atra. Asian J. Agric. Food. Sci. 2018, 6, 123–128. [Google Scholar] [CrossRef] [Green Version]
  36. Kostecka, M.; Niewiadomy, A. Antifungal activity of new series of compound against Ascosphaera apis. Mikol. Lek. 2010, 17, 169–171. [Google Scholar]
  37. Chorbinski, P. Susceptibility of Ascosphaera apis strains to antifungal preparations. Med. Weter. 2003, 59, 1137–1139. [Google Scholar]
  38. Sarwar, M. Fungal diseases of honey bees (Hymenoptera: Apidae) that induce considerable losses to colonies and protocol for treatment. Int. J. Zool. Stud. 2016, 1, 8–13. [Google Scholar]
  39. Frazier, M.; Mullin, C.; Frazier, J.; Ashcraft, S. What have pesticides got to do with it? Am. Bee J. 2008, 148, 521–524. [Google Scholar]
  40. Ansari, M.J.; Al-Ghamdi, A.; Usmani, S.; Khan, K.A.; Alqarni, A.S.; Kaur, M.; Al-Waili, N. In vitro evaluation of the effects of some plant essential oils on Ascosphaera apis, the causative agent of Chalkbrood disease. Saudi J. Biol. Sci. 2017, 24, 1001–1006. [Google Scholar] [CrossRef] [Green Version]
  41. Chantawannakul, P.; Puchanichanthranon, T.; Wongsiri, S. Inhibitory effects of some medicinal plant extracts on the growth of Ascosphaera apis. ACTA Hortic. 2005, 678, 183–189. [Google Scholar] [CrossRef]
  42. Chaimanee, V.; Thongtue, U.; Sornmai, N.; Songsri, S.; Pettis, J.S. Antimicrobial activity of plant extracts against the honeybee pathogens, Paenibacillus larvae and Ascosphaera apis and their topical toxicity to Apis mellifera adults. J. Appl. Microbiol. 2017, 123, 1160–1167. [Google Scholar] [CrossRef] [PubMed]
  43. Boudegga, H.; Boughalleb, N.; Barbouche, N.; Ben Hamouda, M.H.; Mahjoub, M.E. In vitro inhibitory actions of some essential oils on Ascosphaera apis, a fungus responsible for honey bee chalkbrood. J. Apic. Res. 2010, 49, 236–242. [Google Scholar] [CrossRef]
  44. Dellacasa, A.D.; Bailac, P.N.; Ponzi, M.I.; Ruffinengo, S.R.; Eguaras, M.J. In vitro activity of essential oils from San Luis-Argentina against Ascosphaera apis. J. Essent. Oil Res. 2003, 15, 282–285. [Google Scholar] [CrossRef]
  45. Dunn, L.L.; Davidson, P.M.; Critzer, F.J. Antimicrobial efficacy of an array of essential oils against lactic acid bacteria. J. Food Sci. 2016, 81, M438–M444. [Google Scholar] [CrossRef] [PubMed]
  46. Testa, B.; Lombardi, S.J.; Macciola, E.; Succi, M.; Tremonte, P.; Iorizzo, M. Efficacy of olive leaf extract (Olea europaea L. cv Gentile di Larino) in marinated anchovies (Engraulis encrasicolus, L.) process. Heliyon 2019, 5, e01727. [Google Scholar] [CrossRef] [Green Version]
  47. García-Ruiz, A.; Bartolomé, B.; Martínez-Rodríguez, A.J.; Pueyo, E.; Martín-Álvarez, P.J.; Moreno-Arribas, M.V. Potential of phenolic compounds for controlling lactic acid bacteria growth in wine. Food Control 2008, 19, 835–841. [Google Scholar] [CrossRef]
  48. Rivas-Sendra, A.; Landete, J.M.; Alcántara, C.; Zúñiga, M. Response of Lactobacillus casei BL23 to phenolic compounds. J. Appl. Microbiol. 2011, 111, 1473–1481. [Google Scholar] [CrossRef] [Green Version]
  49. Lombardi, S.J.; Tremonte, P.; Succi, M.; Testa, B.; Pannella, G.; Tipaldi, L.; Sorrentino, E.; Coppola, R.; Iorizzo, M. Effect of phenolic compounds on the growth and L-malic acid metabolism of Oenococcus oeni. J. Life Sci. 2012, 6, 1225. [Google Scholar] [CrossRef]
  50. Raymann, K.; Moran, N.A. The role of the gut microbiome in health and disease of adult honey bee workers. Curr. Opin. Insect. Sci. 2018, 26, 97–104. [Google Scholar] [CrossRef]
  51. Wu, M.; Sugimura, Y.; Taylor, D.; Yoshiyama, M. Honeybee gastrointestinal bacteria for novel and sustainable disease control strategies. J. Dev. Sustain. Agric. 2013, 8, 85–90. [Google Scholar] [CrossRef]
  52. Crowley, S.; Mahony, J.; van Sinderen, D. Current perspectives on antifungal lactic acid bacteria as natural bio-preservatives. Trends Food Sci. Technol. 2013, 33, 93–109. [Google Scholar] [CrossRef]
  53. Le Lay, C.; Coton, E.; Le Blay, G.; Chobert, J.M.; Haertlé, T.; Choiset, Y.; Van Long, N.N.; Meslet-Cladière, L.; Mounier, J. Identification and quantification of antifungal compounds produced by lactic acid bacteria and propionibacteria. Int. J. Food Microbiol. 2016, 239, 79–85. [Google Scholar] [CrossRef] [PubMed]
  54. Ngang, J.J.E.; Yadang, G.; Kamdem, S.L.S.; Kouebou, C.P.; Fanche, S.A.Y.; Kougan, D.L.T.; Tsoungui, A.; Etoa, F.X. Antifungal properties of selected lactic acid bacteria and application in the biological control of ochratoxin A producing fungi during cocoa fermentation. Biocontrol Sci. Technol. 2015, 25, 245–259. [Google Scholar] [CrossRef]
  55. Sorrentino, E.; Tremonte, P.; Succi, M.; Iorizzo, M.; Pannella, G.; Lombardi, S.J.; Sturchio, M.; Coppola, R. Detection of Antilisterial Activity of 3-Phenyllactic Acid Using Listeria innocua as a Model. Front. Microbiol. 2018, 9, 1373. [Google Scholar] [CrossRef] [PubMed]
  56. Kleerebezem, M.; Hols, P.; Bernard, E.; Rolain, T.; Zhou, M.; Siezen, R.J.; Bron, P.A. The extracellular biology of the lactobacilli. FEMS Microbiol. Rev. 2010, 34, 199–230. [Google Scholar] [CrossRef]
  57. Kinoshita, H.; Uchida, H.; Kawai, Y.; Kawasaki, T.; Wakahara, N.; Matsuo, H.; Watanabe, M.; Kitazawa, H.; Ohnuma, S.; Miura, K.; et al. Cell surface Lactobacillus plantarum LA 318 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) adheres to human colonic mucin. J. Appl. Microbiol. 2008, 104, 1667–1674. [Google Scholar] [CrossRef]
  58. Åvall-Jääskeläinen, S.; Palva, A. Lactobacillus surface layers and their applications. FEMS Microbiol. Rev. 2005, 29, 511–529. [Google Scholar] [CrossRef] [Green Version]
  59. Janashia, I.; Choiset, Y.; Jozefiak, D.; Déniel, F.; Coton, E.; Akbar, A.; Moosavi-Movahedi, A.A.; Chanishvili, N.; Haertlé, T. Beneficial protective role of endogenous lactic acid bacteria against mycotic contamination of honeybee beebread. Probiot. Antimicrob. Proteins 2018, 10, 638–646. [Google Scholar] [CrossRef]
  60. Daisley, B.A.; Pitek, A.P.; Chmiel, J.A.; Al, F.K.; Chernyshova, A.M.; Faragalla, K.M.; Burton, J.P.; Thompson, G.J.; Reid, G. Novel probiotic approach to counter Paenibacillus larvae infection in honey bees. ISME J. 2020, 14, 476–491. [Google Scholar] [CrossRef] [Green Version]
  61. Santarmaki, V.; Kourkoutas, Y.; Zoumpopoulou, G.; Mavrogonatou, E.; Kiourtzidis, M.; Chorianopoulos, N.; Tassou, C.; Tsakalidou, E.; Simopoulos, C.; Ypsilantis, P. Survival, intestinal mucosa adhesion, and immunomodulatory potential of Lactobacillus plantarum strains. Curr. Microbiol. 2017, 74, 1061–1067. [Google Scholar] [CrossRef] [PubMed]
  62. Trunk, T.; Khalil, H.S.; Leo, J.C. Bacterial autoaggregation. AIMS Microbiol. 2018, 4, 140–164. [Google Scholar] [CrossRef] [PubMed]
  63. Del Re, B.; Sgorbati, B.; Miglioli, M.; Palenzona, D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 2000, 31, 438–442. [Google Scholar] [CrossRef]
  64. Pessoa, W.F.B.; Melgaço, A.C.C.; de Almeida, M.E.; Ramos, L.P.; Rezende, R.P.; Romano, C.C. In vitro activity of Lactobacilli with probiotic potential isolated from Cocoa fermentation against Gardnerella vaginalis. BioMed Res. Int. 2017, 2017, 3264194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Bouchard, D.S.; Bianca Seridan, B.; Saraoui, T.; Rault, L.; Germon, P.; Gonzalez-Moreno, C.; Nader-Macias, F.M.E.; Baud, D.; François, P.; Chuat, V.; et al. Lactic acid bacteria isolated from bovine mammary microbiota: Potential allies against bovine mastitis. PLoS ONE 2015, 29, e144831. [Google Scholar] [CrossRef]
  66. Gandomi, H.; Farhangfar, A.; Misaghi, A.; Noori, N. Auto and co-aggregation, hydrophobicity and adhesion properties of Lactobacillus plantarum strains isolated from Siahmazgi traditional cheese. Food Health J. 2019, 2, 1–5. [Google Scholar]
  67. Collado, M.C.; Meriluoto, J.; Salminen, S. Adhesion and aggregation properties of probiotic and pathogen strains. Eur. Food Res. Technol. 2008, 226, 1065–1073. [Google Scholar] [CrossRef]
  68. Ekmekci, H.; Aslim, B.; Ozturk, S. Characterization of vaginal lactobacilli coaggregation ability with Escherichia coli. Microbiol. Immunol. 2009, 53, 59–65. [Google Scholar] [CrossRef]
  69. Marin, M.L.; Benito, Y.; Pin, C.; Fernandez, M.F.; Garcia, M.L.; Selgas, M.D.; Casas, C. Lactic acid bacteria: Hydrophobicity and strength of attachment to meat surfaces. Lett. Appl. Microbiol. 1997, 24, 14–18. [Google Scholar] [CrossRef]
  70. O’Toole, G.; Kaplan, H.B.; Kolter, R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000, 54, 49–79. [Google Scholar] [CrossRef]
  71. Sakandar, H.A.; Kubow, S.; Sadiq, F.A. Isolation and in-vitro probiotic characterization of fructophilic lactic acid bacteria from Chinese fruits and flowers. LWT Food Sci. Technol. 2019, 104, 70–75. [Google Scholar] [CrossRef]
  72. Audisio, M.C.; Torres, M.J.; Sabaté, D.C.; Ibarguren, C.; Apella, M.C. Properties of different lactic acid bacteria isolated from Apis mellifera L. bee-gut. Microbiol. Res. 2011, 166, 1–13. [Google Scholar] [CrossRef] [PubMed]
  73. Van de Guchte, M.; Serror, P.; Chervaux, C.; Smokvina, T.; Ehrlich, S.D.; Maguin, E. Stress responses in lactic acid bacteria. Anton Leeuwenhoek 2002, 82, 187–216. [Google Scholar] [CrossRef]
  74. Papadimitriou, K.; Alegría, Á.; Bron, P.A.; de Angelis, M.; Gobbetti, M.; Kleerebezem, M.; Lemos, J.A.; Linares, D.M.; Ross, P.; Stanton, C.; et al. Stress physiology of lactic acid bacteria. Microbiol. Mol. Biol. Rev. 2016, 80, 837–890. [Google Scholar] [CrossRef] [Green Version]
  75. Vasileva, T.; Bivolarski, V.; Michailova, G.; Salim, A.; Rabadjiev, Y.; Ivanova, I.; Iliev, I. Glucansucrases produced by fructophilic lactic acid bacteria Lactobacillus kunkeei H3 and H25 isolated from honeybees. J. Basic Microbiol. 2017, 57, 68–77. [Google Scholar] [CrossRef]
  76. Meng, X.; Gangoiti, J.; Wang, X.; Grijpstra, P.; Van Leeuwen, S.S.; Pijning, T.; Dijkhuizen, L. Biochemical characterization of a GH70 protein from Lactobacillus kunkeei DSM 12361 with two catalytic domains involving branching sucrase activity. Appl. Microbiol. Biotechnol. 2018, 102, 7935–7950. [Google Scholar] [CrossRef]
  77. Davey, M.E.; O’toole, G.A. Microbial biofilms: From ecology to molecular genetics. Microbiol. Mol. Biol. Rev. 2000, 64, 847–867. [Google Scholar] [CrossRef] [Green Version]
  78. Djukic, M.; Poehlein, A.; Strauß, J.; Tann, F.J.; Leimbach, A.; Hoppert, M.; Daniel, R. High quality draft genome of Lactobacillus kunkeei EFB6, isolated from a German European foulbrood outbreak of honeybees. Stand. Genom. Sci. 2015, 10, 16. [Google Scholar] [CrossRef] [Green Version]
  79. Tamarit, D.; Ellegaard, K.M.; Wikander, J.; Olofsson, T.; Vasquez, A.; Andersson, S.G. Functionally structured genomes in Lactobacillus kunkeei colonizing the honey crop and food products of honeybees and stingless bees. Genome Biol. Evol. 2015, 7, 1455–1473. [Google Scholar] [CrossRef]
  80. Billiet, A.; Meeus, I.; Cnockaert, M.; Vandamme, P.; Van Oystaeyen, A.; Wäckers, F.; Smagghe, G. Effect of oral administration of lactic acid bacteria on colony performance and gut microbiota in indoor-reared bumblebees (Bombus terrestris). Apidologie 2017, 48, 41–50. [Google Scholar] [CrossRef] [Green Version]
  81. Alberoni, D.; Gaggìa, F.; Baffoni, L.; Di Gioia, D. Beneficial microorganisms for honey bees: Problems and progresses. Appl. Microbiol. Biotechnol. 2016, 100, 9469–9482. [Google Scholar] [CrossRef] [PubMed]
  82. Crotti, E.; Balloi, A.; Hamdi, C.; Sansonno, L.; Marzorati, M.; Gonella, E.; Favia, G.; Cherif, A.; Bandi, C.; Alma, A.; et al. Microbial symbionts: A resource for the management of insect-related problems. Microb. Biotechnol. 2011, 5, 307–317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Maruščáková, I.C.; Schusterová, P.; Bielik, B.; Toporčák, J.; Bíliková, K.; Mudroňová, D. Effect of application of probiotic pollen suspension on immune response and gut microbiota of honey bees (Apis mellifera). Probiot. Antimicrob. Proteins 2020, 1–8. [Google Scholar] [CrossRef] [PubMed]
  84. Kwong, W.K.; Mancenido, A.L.; Moran, N.A. Immune system stimulation by the native gut microbiota of honey bees. R. Soc. Open Sci. 2017, 4, 170003. [Google Scholar] [CrossRef] [Green Version]
  85. Di Donato, A.P. Characterization of Lactic Acid Bacteria Isolated from Apis mellifera L. and Hive Products. Master’s Thesis, University of Molise, Campobasso, Italy, 15 February 2016. [Google Scholar]
  86. Magnusson, J.; Ström, K.; Roos, S.; Sjögren, J.; Schnürer, J. Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiol. Lett. 2003, 219, 129–135. [Google Scholar] [CrossRef] [Green Version]
  87. Cozzolino, A.; Vergalito, F.; Tremonte, P.; Iorizzo, M.; Lombardi, S.J.; Sorrentino, E.; Luongo, D.; Coppola, R.; Di Marco, R.; Succi, M. Preliminary evaluation of the safety and probiotic potential of Akkermansia muciniphila DSM 22959 in Comparison with Lactobacillus rhamnosus GG. Microorganisms 2020, 8, 189. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Antibiotics 09 00262 g001 550
Figure 1. Heatmap of inhibition (%) against Ascosphaera apis DSM 3116 (radial growth) on Malt Extract Agar (MEA) plates after 6 days, using culture broth (CB), cell pellets (CPs), cell-free supernatants (CFSs), and cell lysates (CLs) of the Lactobacillus kunkeei strains.
Figure 1. Heatmap of inhibition (%) against Ascosphaera apis DSM 3116 (radial growth) on Malt Extract Agar (MEA) plates after 6 days, using culture broth (CB), cell pellets (CPs), cell-free supernatants (CFSs), and cell lysates (CLs) of the Lactobacillus kunkeei strains.
Antibiotics 09 00262 g001
Antibiotics 09 00262 g002 550
Figure 2. Inhibitory activity after 6 days on MEA agar plates of L. kunkeei K7 against A. apis DSM 3116. (A): A. apis; (B): A. apis + CL (cell lysate); (C): A. apis + CP (cell pellet); (D): A. apis + CFS (cell-free supernatant).
Figure 2. Inhibitory activity after 6 days on MEA agar plates of L. kunkeei K7 against A. apis DSM 3116. (A): A. apis; (B): A. apis + CL (cell lysate); (C): A. apis + CP (cell pellet); (D): A. apis + CFS (cell-free supernatant).
Antibiotics 09 00262 g002
Antibiotics 09 00262 g003 550
Figure 3. Adhesion of the L. kunkeei strains to toluene and xylene (expressed as hydrophobicity %) measured using bacterial ability to adhere to hydrocarbons (BATH) test after different contact times (CTs). (A): 15 min; (B): 30 min; (C): 60 min.
Figure 3. Adhesion of the L. kunkeei strains to toluene and xylene (expressed as hydrophobicity %) measured using bacterial ability to adhere to hydrocarbons (BATH) test after different contact times (CTs). (A): 15 min; (B): 30 min; (C): 60 min.
Antibiotics 09 00262 g003
Antibiotics 09 00262 g004 550
Figure 4. Biofilm formation in vitro of the L. kunkeei strains, expressed as Optical Density (OD) value at 580 nm.
Figure 4. Biofilm formation in vitro of the L. kunkeei strains, expressed as Optical Density (OD) value at 580 nm.
Antibiotics 09 00262 g004
Table
Table 1. Auto-aggregation (%) of the L. kunkeei strains after 1, 2, 5, and 24 h of incubation at 37 °C. Results are shown as mean ± standard deviation (n = 3). Different lowercase letters (a-d) indicate significant differences by column, and different uppercase letters (A-I) in each row indicate significant differences by row (p < 0.05).
Table 1. Auto-aggregation (%) of the L. kunkeei strains after 1, 2, 5, and 24 h of incubation at 37 °C. Results are shown as mean ± standard deviation (n = 3). Different lowercase letters (a-d) indicate significant differences by column, and different uppercase letters (A-I) in each row indicate significant differences by row (p < 0.05).
Time (Hours)Auto-Aggregation (%)
K7K18K34K40K41K45K55K64K112DSM 12361
111.10 ± 0.88Ga4.49 ± 0.14Ca4.51 ± 0.10Ca15.41 ± 0.54Ha3.25 ± 0.12Ba0.76 ± 0.02Aa5.55 ± 0.22Da6.76 ± 0.50Ea9.48 ± 0.16Fa9.32 ± 0.20Fa
218.40 ± 1.18Fb8.62 ± 0.36Cb10.94 ± 0.89Db17.40 ± 1.08Fb7.56 ± 0.32Bb2.11 ± 0.10Ab10.43 ± 0.27Db10.61 ± 0.35Db16.10 ± 0.96Fb13.66 ± 0.35Eb
522.71 ± 1.00Fc12.41 ± 0.16Cc11.31 ± 0.34Bb24.94 ± 0.04Hc25.20 ± 0.19Ic6.23 ± 0.59Ac14.82 ± 0.98Dc15.27 ± 0.12Dc23.42 ± 0.31Gc19.70 ± 0.65Ec
2453.42 ± 1.21Bd62.23 ± 1.32Dd65.62 ± 1.37Ec56.52 ± 1.95Cd68.10 ± 1.71Fd41.81 ± 0.42Ad62.30 ± 0.99Dd56.12 ± 2.39Cd55.80 ± 0.94Cd55.42 ± 3.21Cd
Table
Table 2. Survival of the L. kunkeei strains in different sugar syrups after 24 and 48 h of incubation at 20 °C. Results are shown as mean ± standard deviation (n = 3). For every sugar syrup, different lowercase letters (a-c) indicate significant differences in columns, and different uppercase letters (A-I) indicate significant differences in rows (p < 0.05).
Table 2. Survival of the L. kunkeei strains in different sugar syrups after 24 and 48 h of incubation at 20 °C. Results are shown as mean ± standard deviation (n = 3). For every sugar syrup, different lowercase letters (a-c) indicate significant differences in columns, and different uppercase letters (A-I) indicate significant differences in rows (p < 0.05).
Time (Hours)Sugar Syrup CompositionSurvival (log CFU/mL) of L. kunkeei Strains
K7K18K34K40K41K45K55K64K112DSM 12361
T040% glucose
20% fructose		8.41 ± 0.02Bc8.38 ± 0.04Bc8.44 ± 0.06Bc8.23 ± 0.03Ac8.19 ± 0.04Ac8.17 ± 0.02Ac8.26 ± 0.05Ac8.24 ± 0.01Ac8.36 ± 0.02Bc8.40 ± 0.04Bc
T247.89 ± 0.01Eb8.10 ± 0.01Gb7.60 ± 0.07Cb7.12 ± 0.05Bb7.20 ± 0.04Bb7.80 ± 0.06Db7.18 ± 0.08Bb6.90 ± 0.04Ab8.01 ± 0.01Fb6.90 ± 0.02Ab
T486.62 ± 0.03Fa7.51 ± 0.02Ha4.90 ± 0.02Ba5.84 ± 0.05Ca6.29 ± 0.01Da6.47 ± 0.02Ea5.84 ± 0.01Ca5.90 ± 0.02Ca6.84 ± 0.03Ga4.80 ± 0.04Aa
T040% glucose
30% fructose		8.66 ± 0.04Ec8.50 ± 0.03Dc8.43 ± 0.05Dc8.06 ± 0.08Ac8.46 ± 0.08Dc8.43 ± 0.02Dc8.25 ± 0.04Bc8.23 ± 0.05Bc8.30 ± 0.02Cc8.45 ± 0.06Dc
T246.23 ± 0.02Db7.12 ± 0.05Gb6.24 ± 0.04Db6.90 ± 0.02Fb6.84 ± 0.01Eb6.11 ± 0.05Cb6.12 ± 0.02Cb6.24 ± 0.06Db5.97 ± 0.02Bb4.97 ± 0.07Ab
T484.54 ± 0.04Da5.75 ± 0.05Ha4.61 ± 0.01Ea4.01 ± 0.02Ba4.98 ± 0.03Ga4.73 ± 0.03Fa5.59 ± 0.01Ia4.94 ± 0.04Ga4.20 ± 0.02Ca2.91 ± 0.01Aa
T050% sucrose 8.20 ± 0.04Bc8.10 ± 0.01Ac8.50 ± 0.03Fc8.40 ± 0.06Dc8.49 ± 0.07Ec8.23 ± 0.01Bc8.10 ± 0.04Ac8.53 ± 0.07Fc8.50 ± 0.06Fc8.30 ± 0.04Cc
T247.20 ± 0.04Bb8.20 ± 0.03Gb7.90 ± 0.02Fb7.79 ± 0.06Eb8.50 ± 0.01Hb7.60 ± 0.02Db7.10 ± 0.01Ab7.60 ± 0.05Db7.50 ± 0.07Cb7.20 ± 0.06Bb
T487.00 ± 0.05Da7.94 ± 0.01Fa5.94 ± 0.02Aa6.85 ± 0.01Ca7.30 ± 0.05Ea6.89 ± 0.02Ca6.85 ± 0.01Ca6.90 ± 0.05Ca6.90 ± 0.06Ca6.50 ± 0.06Ba

Share and Cite

MDPI and ACS Style

Iorizzo, M.; Lombardi, S.J.; Ganassi, S.; Testa, B.; Ianiro, M.; Letizia, F.; Succi, M.; Tremonte, P.; Vergalito, F.; Cozzolino, A.; et al. Antagonistic Activity against Ascosphaera apis and Functional Properties of Lactobacillus kunkeei Strains. Antibiotics 2020, 9, 262. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9050262

AMA Style

Iorizzo M, Lombardi SJ, Ganassi S, Testa B, Ianiro M, Letizia F, Succi M, Tremonte P, Vergalito F, Cozzolino A, et al. Antagonistic Activity against Ascosphaera apis and Functional Properties of Lactobacillus kunkeei Strains. Antibiotics. 2020; 9(5):262. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9050262

Chicago/Turabian Style

Iorizzo, Massimo, Silvia Jane Lombardi, Sonia Ganassi, Bruno Testa, Mario Ianiro, Francesco Letizia, Mariantonietta Succi, Patrizio Tremonte, Franca Vergalito, Autilia Cozzolino, and et al. 2020. "Antagonistic Activity against Ascosphaera apis and Functional Properties of Lactobacillus kunkeei Strains" Antibiotics 9, no. 5: 262. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9050262

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop